Evidence map›Paper›PMID 29416619›Full record

ArticleOncotarget2018

The inhibitory activity of gallic acid against DNA methylation: application of gallic acid on epigenetic therapy of human cancers.

Yui-Ping Weng, Pin-Feng Hung, Wen-Yen Ku, Chang-Yuan Chang, Bo-Han Wu, Ming-Han Wu, Jau-Ying Yao, Ji-Rui Yang, Chia-Huei Lee

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Beneficial Effects ofNutrients · 2024
    Review
  9. Article
  10. How gallic acid regulates molecular signaling: role in cancer drug resistance.Medical oncology (Northwood, London, England) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Polyphenols as Potent Epigenetics Agents for Cancer.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Potential ofMolecules (Basel, Switzerland) · 2022
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yui-Ping WengGraduate Institute of Biomedical Science, Chung Hwa University of Medical Technology, Tainan, Taiwan.
Pin-Feng HungNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Wen-Yen KuGraduate Institute of Biomedical Science, Chung Hwa University of Medical Technology, Tainan, Taiwan.
Chang-Yuan ChangGraduate Institute of Biomedical Science, Chung Hwa University of Medical Technology, Tainan, Taiwan.
Bo-Han WuGraduate Institute of Biomedical Science, Chung Hwa University of Medical Technology, Tainan, Taiwan.
Ming-Han WuGraduate Institute of Biomedical Science, Chung Hwa University of Medical Technology, Tainan, Taiwan.
Jau-Ying YaoNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Ji-Rui YangNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Chia-Huei LeeNational Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
Chung Hwa University of Medical Technology · TWNational Health Research Institutes · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenome aberrations have been observed in tobacco-associated human malignancies. (-)-epigallocatechin-3-gallate (EGCG) has been proven to modulate gene expression by targeting DNA methyltransferases (DNMTs) through a proposed mechanism involving the gallate moiety of EGCG. We show that gallic acid (GA) changes the methylome of lung cancer and pre-malignant oral cell lines and markedly reduces both nuclear and cytoplasmic DNMT1 and DNMT3B within 1 week. GA exhibits stronger cytotoxicity against the lung cancer cell line H1299 than EGCG. We found that GA reactivates the growth arrest and DNA damage-inducible 45 (GADD45) signaling pathway may through the demethylation of CCNE2 and CCNB1 in H1299 cells. To improve the epigenetic anti-cancer activities of oolong tea, we identified a fungus,

Indexed as

chemopreventionDNA methyltransferaseepigeneticsgallic acidpost-fermentation oolong tea extract

Identifiers

PMID29416619
PMCPMC5787471
OpenAlexW2772005833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.